VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Total Liabilities | ₹464 Cr | ₹401 Cr | ₹343 Cr | ₹213 Cr |
What is the latest Total Liabilities ratio of VALIANT LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹464 Cr |
| Mar2025 | ₹401 Cr |
| Mar2024 | ₹343 Cr |
| Mar2023 | ₹213 Cr |
How is Total Liabilities of VALIANT LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹464 Cr | 15.75 | |
| Mar2025 | ₹401 Cr | 16.97 | |
| Mar2024 | ₹343 Cr | 60.91 | |
| Mar2023 | ₹213 Cr | - | |
Compare Total Liabilities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹572.1 Cr | -7.6% | -13.8% | 26.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,291.0 Cr | -1.8% | 7.6% | 11.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹305,014.0 Cr | 3.7% | 27.2% | 71.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,333.0 Cr | -2.3% | 1.5% | 23.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,017.0 Cr | 0.6% | 13.4% | 15.7% | Stock Analytics | |
| CIPLA | ₹112,539.0 Cr | -1.3% | 6.1% | -6.9% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | -7.6% |
-13.8% |
26.8% |
| SENSEX | 0.7% |
11.7% |
-2% |
You may also like the below Video Courses